Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA taps Flatiron’s Abernethy for oversight post

fiercebiotechDecember 25, 2018

Tag: FDA , Flatiron , Abernethy , oversight

PharmaSources Customer Service